As we know, Biopharmaceutical product development is a complex, costly and risky undertaking with an overall failure rate of > 96%, and a 90% failure rate during development. Our experts in product development (PD) know what it takes to deliver new therapies to the patients that need them and bring deep scientific and product development expertise to every development challenge.
